GVHD-Free Survival, Safety Shown Via Combo in Blood Cancers

A multidose regimen of the novel human fusion protein with a treatment combination may result in prolonged survival after acute graft-versus-host-disease.

Related Keywords

Paulj Martin , ,Fred Hutchinson Cancer Center ,University Of Washington ,Whaca Mole While Managing ,New Treatments Lend ,Positive Outlook ,Patients With ,News ,Blood Cancer ,Graft Versus Host Disease ,